Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthay

Showing results (1201-1210 of 1,339) with videos related to

Pageof 134
Sort By:
International Journal of Cancer|March 27, 2001
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplificationD Plantaz, J Vandesompele, N Van Roy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2012
Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trialKatherine K Matthay, Brian Weiss, Judith G Villablanca, et al.
The Journal of Clinical Investigation|July 9, 2024
A fibroblast-dependent TGF-β1/sFRP2 noncanonical Wnt signaling axis promotes epithelial metaplasia in idiopathic pulmonary fibrosisMax L Cohen, Alexis N Brumwell, Tsung Che Ho, et al.
British Journal of Cancer|January 10, 2024
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trialMichael D Hogarty, David S Ziegler, Andrea Franson, et al.
Intensive Care Medicine|July 20, 2023
Exposure to ambient air pollutants and acute respiratory distress syndrome risk in sepsisJohn P Reilly, Zhiguo Zhao, Michael G S Shashaty, et al.
Critical Care Explorations|August 4, 2021
Plasma Metabolites in Early Sepsis Identify Distinct Clusters Defined by Plasma LipidsAngela J Rogers, Aleksandra Leligdowicz, Kévin Contrepois, et al.
Thorax|September 14, 2014
Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosisDaryle J DePianto, Sanjay Chandriani, Alexander R Abbas, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Gut bacterial lactate stimulates lung epithelial mitochondria and exacerbates acute lung injuryVaibhav Upadhyay, Edwin F Ortega, Luis A Ramirez Hernandez, et al.
American Journal of Respiratory Cell and Molecular Biology|June 9, 2022
New Insights into Clinical and Mechanistic Heterogeneity of the Acute Respiratory Distress Syndrome: Summary of the Aspen Lung Conference 2021Thomas R Martin, Rachel L Zemans, Lorraine B Ware, et al.
American Journal of Respiratory and Critical Care Medicine|August 11, 2025
Host-Microbe Multiomic Profiling Predicts Mortality in SepsisNatasha Spottiswoode, Lucile P Neyton, Eran Mick, et al.
Pageof 134

Showing results (1201-1210 of 1,339) with videos related to

Sort By:
Pageof 134
International Journal of Cancer|March 27, 2001
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplificationD Plantaz, J Vandesompele, N Van Roy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2012
Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trialKatherine K Matthay, Brian Weiss, Judith G Villablanca, et al.
The Journal of Clinical Investigation|July 9, 2024
A fibroblast-dependent TGF-β1/sFRP2 noncanonical Wnt signaling axis promotes epithelial metaplasia in idiopathic pulmonary fibrosisMax L Cohen, Alexis N Brumwell, Tsung Che Ho, et al.
British Journal of Cancer|January 10, 2024
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trialMichael D Hogarty, David S Ziegler, Andrea Franson, et al.
Intensive Care Medicine|July 20, 2023
Exposure to ambient air pollutants and acute respiratory distress syndrome risk in sepsisJohn P Reilly, Zhiguo Zhao, Michael G S Shashaty, et al.
Critical Care Explorations|August 4, 2021
Plasma Metabolites in Early Sepsis Identify Distinct Clusters Defined by Plasma LipidsAngela J Rogers, Aleksandra Leligdowicz, Kévin Contrepois, et al.
Thorax|September 14, 2014
Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosisDaryle J DePianto, Sanjay Chandriani, Alexander R Abbas, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Gut bacterial lactate stimulates lung epithelial mitochondria and exacerbates acute lung injuryVaibhav Upadhyay, Edwin F Ortega, Luis A Ramirez Hernandez, et al.
American Journal of Respiratory Cell and Molecular Biology|June 9, 2022
New Insights into Clinical and Mechanistic Heterogeneity of the Acute Respiratory Distress Syndrome: Summary of the Aspen Lung Conference 2021Thomas R Martin, Rachel L Zemans, Lorraine B Ware, et al.
American Journal of Respiratory and Critical Care Medicine|August 11, 2025
Host-Microbe Multiomic Profiling Predicts Mortality in SepsisNatasha Spottiswoode, Lucile P Neyton, Eran Mick, et al.
Pageof 134